EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

SUL-138 mitigates accelerated endothelial aging and protects the kidney

Annika A Jüttner iD, Sabrina Ribeiro Gonsalez, Martijn H van Heugten, Ehsan Ataei Ataabadi, Keivan Golshiri, Ewout J Hoorn, Marian Clahsen-van Groningen, Rene de Vries, Ingrid M Garrelds, Dennis Schutter, A H Jan Danser, Adrianus C van der Graaf und 6 weitere

Clinical Science · 12.11.2025 · 139 (21) · 1321-1336

DOI: 10.1042/cs20255735 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Clinical Science, online erschienen am 06.11.2025. Verfasst von Annika A Jüttner und 17 weiteren Autor:innen. Beteiligte Einrichtung: Division of Vascular Medicine and Pharmacology, Department of Internal Medicine, Erasmus MC, University Medical Center, Rotterdam, Netherlands. Hauptthemen laut MEDLINE: Kidney, Endothelium, Vascular, Cellular Senescence, Aging. Die Arbeit wurde bisher 5-mal zitiert (Crossref) und nennt 61 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Vascular aging is marked by increased levels of reactive oxygen species in endothelial cells. Reactive oxygen species can, among others, be produced by dysfunctional mitochondria, contributing to acceleration of vascular aging by promoting DNA damage response and senescence. In the aged vasculature, impaired endothelial cell function causes decreased vasodilation, which may also have an impact on peripheral organs such as the kidney. The aim of this study was to investigate the effect of chronic treatment with SUL-138 (30 mg/kg/day), a novel mitochondrial protective compound, on DNA damage-prompted, accelerated endothelial aging and associated kidney dysfunction in mice. Endothelial-specific aging was induced by knock-out (KO) of DNA repair endonuclease Ercc1 in mice [endothelial-cell specific Ercc1 KO (EC-KO) mice]. We showed that impaired endothelium-dependent vasodilation and expression of DNA damage response markers in EC-KO mice were restored after the treatment with SUL-138. The underlying mechanism of improved vasodilation was an increase in endothelium-derived hyperpolarization (EDH). Endothelial-specific aging induced tubular injury, sodium wasting, and increased inflammatory markers in the kidney, which were normalized by the treatment with SUL-138. We conclude that accelerated endothelial aging adversely affects vascular function and causes kidney tubular injury. SUL-138 rescues endothelial aging, restores vasodilation by increasing EDH, and protects the kidney. Thus, preservation of mitochondrial function is a potential pharmacotherapeutic target in aging-related dysfunction provoked by the DNA damage response.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

KidneyEndothelium, VascularCellular SenescenceAgingEndothelial CellsAnimalsMice, KnockoutDNA DamageVasodilationMaleMice, Inbred C57BLEndonucleasesMiceDNA-Binding ProteinsMitochondria

Stichwörter der Autor:innen

SUL-138agingendothelial cellsmitochondriatubular injuryvasodilation

Substanzen

Ercc1 protein, mouseEndonucleasesDNA-Binding Proteins

Autor:innen und Institutionen

  • Division of Vascular Medicine and Pharmacology, Department of Internal Medicine, Erasmus MC, University Medical Center, Rotterdam, Netherlands.
  • Division of Nephrology and Transplantation, Department of Internal Medicine, Erasmus MC, University Medical Center, Rotterdam, Netherlands.
  • Department of Pathology, Erasmus MC, University Medical Center, Rotterdam, Netherlands.
  • Sulfateq B.V., Groningen, Netherlands.
  • Department of Clinical Pharmacy and Pharmacology, University Medical Center Groningen, University of Groningen, Groningen, Netherlands.
  • Division of Endocrinology, Department of Internal Medicine, Erasmus MC, University Medical Center, Rotterdam, Netherlands.

ORCID-Profile: Annika A Jüttner, Anton J M Roks

Zitieren

APA

Jüttner, A. A., Ribeiro Gonsalez, S., van Heugten, M. H., Ataei Ataabadi, E., Golshiri, K., Hoorn, E. J., Clahsen-van Groningen, M., de Vries, R., Garrelds, I. M., Schutter, D., Danser, A. H. J., van der Graaf, A. C., Swart, D. H., Deelman, L. E., Henning, R. H., Visser, J. A., Krenning, G., & Roks, A. J. M. (2025). SUL-138 mitigates accelerated endothelial aging and protects the kidney. Clinical Science, 139(21), 1321-1336. https://doi.org/10.1042/cs20255735

Vancouver

Jüttner AA, Ribeiro Gonsalez S, van Heugten MH, Ataei Ataabadi E, Golshiri K, Hoorn EJ, et al. SUL-138 mitigates accelerated endothelial aging and protects the kidney. Clinical Science. 2025;139(21):1321-1336. doi:10.1042/cs20255735

BibTeX
@article{Jttner2025,
  author = {Jüttner, Annika A and Ribeiro Gonsalez, Sabrina and van Heugten, Martijn H and Ataei Ataabadi, Ehsan and Golshiri, Keivan and Hoorn, Ewout J and Clahsen-van Groningen, Marian and de Vries, Rene and Garrelds, Ingrid M and Schutter, Dennis and Danser, A H Jan and van der Graaf, Adrianus C and Swart, Daniël H and Deelman, Leo E and Henning, Robert H and Visser, Jenny A and Krenning, Guido and Roks, Anton J M},
  title = {SUL-138 mitigates accelerated endothelial aging and protects the kidney},
  journal = {Clinical Science},
  year = {2025},
  volume = {139},
  number = {21},
  pages = {1321--1336},
  doi = {10.1042/cs20255735}
}
Kostenlos starten →